Skip to content

Clinical trials

Respiratory Tract Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Country / region: United States Clear all

167 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20014
20031
20061
20073
20083
20099
20102
20112
20125
201310
201410
20157
201610
201711
20186
20196
202011
20215
202211
202314
20246
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98
Recruiting22
Terminated21
Unknown status13
Active, not recruiting9
Withdrawn3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca18
National Center for Research Resources (NCRR)9
Medicago6
Revolution Medicines, Inc.6
Blueprint Medicines Corporation4
Eli Lilly and Company4
Vertex Pharmaceuticals Incorporated4
BioNTech SE3
Columbia University3
Novartis Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases167
Lung Diseases100
Asthma31
Lung Diseases, Obstructive31
Bronchial Diseases29
Respiratory Tract Infections28
Lung Neoplasms27
Neoplasms27
Respiratory Tract Neoplasms27
Thoracic Neoplasms26

Trials

Showing 1 to 25 of 167. Each trial links to its page on Pharma Observatory.

67 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.